Opus Genetics (IRD) rated Hold: valuation hinges on AAV gene therapy success. Track LCA5 Phase 3, 2026 data catalysts & ...
A major mouse study found that some inherited traits are passed down through epigenetic changes that break the classic rules ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...
A new statistical framework developed by researchers at the Johns Hopkins Bloomberg School of Public Health, Johns Hopkins ...
An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help ...
As predictive medicine advances, legal scholars warn that decades-old federal guidelines could set up a potential clash between your genes and your job.
Yeast’s emergence as a model organism reshaped scientific discovery in cell biology, genetics, and more.
Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells that ...
A new study suggests that the long-standing Mendelian view of genetics has some blind spots.
View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results